Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating early continuous infusion of Hypertonic saline solution (HSS) on neurological outcome at 6 months in patients with traumatic b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic saline solution (Hypertonic saline)

Snippet

Sponsor: Nantes University Hospital | Conditions: TBI Traumatic Brain Injury | Phase 3 | Status: RECRUITING